Peter DiLaura is the founder of Sonoma BioTherapeutics. Sonoma BioTherapeutics has raised $40M in total funding. Latest round: Series A. Based in Seattle, WA.
Peter DiLaura is the Chief Business Officer (CBO) at Sonoma BioTherapeutics, a biotech company developing regulatory T cell therapies for autoimmune and degenerative diseases. He previously served as CEO of Initial Therapeutics, a South San Francisco-based company.
Full founder directory · Investor directory · Company funding database · Fundraising library